O.R. Procedures for Obesity with MCC DRG

DRG 619 encompasses operating room procedures for obesity accompanied by a Major Complication or Comorbidity, reflecting higher clinical complexity. Correct assignment to this Diagnosis-Related Group influences inpatient reimbursement under Medicare by aligning payment with expected resource use.

DRG 619 Overview

DRG 619 covers inpatient hospital cases involving operating room procedures for obesity when a Major Complication or Comorbidity is present, typically including bariatric surgeries performed in patients with significant additional diagnoses. This Diagnosis-Related Group groups higher-resource cases that require more complex perioperative management and extended resource use. It matters for Medicare payment because hospitals receive higher prospective reimbursement under this Diagnosis-Related Group to reflect the increased clinical complexity and costs. Accurate coding of the Major Complication or Comorbidity and the specific procedure affects proper assignment to this Diagnosis-Related Group.

DRG 619 Overview

Randomized controlled trials comparing different bariatric surgical techniques and perioperative care bundles (for example, laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass and enhanced recovery protocols) focusing on patients with severe obesity and at least one major comorbidity. These studies enroll adult inpatients who meet criteria for operative management of obesity with MCC (such as type 2 diabetes, obstructive sleep apnea, or significant cardiovascular disease) to evaluate short-term surgical morbidity, perioperative complication rates, and index hospitalization resource use. Results directly inform surgical decision-making, risk adjustment, and expected inpatient costs for providers and payers managing high-risk DRG 619 cases.
Comparative effectiveness and health-services research assessing perioperative optimization strategies and complication prevention in high-risk obese patients undergoing O.R. procedures. Examples include trials or pragmatic studies of preoperative medical optimization (glycemic and blood pressure control), respiratory therapy protocols, or venous thromboembolism prophylaxis tailored to patients with obesity plus major comorbidities; populations typically include patients admitted for planned bariatric or metabolic operations who carry additional MCCs. Findings help hospitals and payers identify which protocols reduce length of stay, readmissions, and costly complications among DRG 619 patients and support evidence-based pathways and bundled payment models.
Prospective cohort and outcomes research focused on post-discharge recovery, long-term comorbidity resolution, and health-economic outcomes after operative treatment for obesity in patients with MCCs. These studies follow patients discharged from index hospitalization to measure durable weight loss, remission of diabetes or improvement in cardiovascular risk factors, readmission rates, and cumulative costs over 1–5 years; cohorts often stratify by baseline severity of comorbidity and perioperative complications. This evidence is relevant to payers and providers for evaluating the longer-term value of high-cost inpatient procedures captured under DRG 619 and for designing post-acute care pathways that may reduce downstream utilization.

Randomized controlled trials comparing different bariatric surgical techniques and perioperative care bundles (for example, laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass and enhanced recovery protocols) focusing on patients with severe obesity and at least one major comorbidity. These studies enroll adult inpatients who meet criteria for operative management of obesity with MCC (such as type 2 diabetes, obstructive sleep apnea, or significant cardiovascular disease) to evaluate short-term surgical morbidity, perioperative complication rates, and index hospitalization resource use. Results directly inform surgical decision-making, risk adjustment, and expected inpatient costs for providers and payers managing high-risk DRG 619 cases.
Comparative effectiveness and health-services research assessing perioperative optimization strategies and complication prevention in high-risk obese patients undergoing O.R. procedures. Examples include trials or pragmatic studies of preoperative medical optimization (glycemic and blood pressure control), respiratory therapy protocols, or venous thromboembolism prophylaxis tailored to patients with obesity plus major comorbidities; populations typically include patients admitted for planned bariatric or metabolic operations who carry additional MCCs. Findings help hospitals and payers identify which protocols reduce length of stay, readmissions, and costly complications among DRG 619 patients and support evidence-based pathways and bundled payment models.
Prospective cohort and outcomes research focused on post-discharge recovery, long-term comorbidity resolution, and health-economic outcomes after operative treatment for obesity in patients with MCCs. These studies follow patients discharged from index hospitalization to measure durable weight loss, remission of diabetes or improvement in cardiovascular risk factors, readmission rates, and cumulative costs over 1–5 years; cohorts often stratify by baseline severity of comorbidity and perioperative complications. This evidence is relevant to payers and providers for evaluating the longer-term value of high-cost inpatient procedures captured under DRG 619 and for designing post-acute care pathways that may reduce downstream utilization.

OpenPayer

O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

Sign up for O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview policy alerts

DRG 619 Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

Sign up for O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview policy alerts

DRG 619 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References